Synergistic effect of terbinafine and amphotericin B in killing Fonsecaea nubica in vitro and in vivo.

Author: HuangHuaiqiu, HuangJiamin, LiMeirong, LuChun, WuXiaoyan, XiLiyan, YinSongchao, ZhangJing

Paper Details 
Original Abstract of the Article :
Chromoblastomycosis is a chronic fungal infection. Itraconazole and terbinafine are the most recommended antifungal drugs for chromoblastomycosis, while amphotericin B is not usually recommended. A patient with chromoblastomycosis in our hospital showed poor clinical responses to itraconazole and ter...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592013/

データ提供:米国国立医学図書館(NLM)

Combating Chromoblastomycosis: A Synergistic Approach

The world of

fungal infections

can be tricky to navigate. This research focuses on

chromoblastomycosis

, a chronic fungal infection, and investigates the potential of combining two antifungal drugs, terbinafine and amphotericin B, to combat this stubborn infection. The authors looked at the effectiveness of the two drugs both in the lab (in vitro) and in a patient (in vivo). They discovered that the combination of these two drugs had a synergistic effect, meaning that the combined effect was greater than the sum of the individual effects. The study concluded that this combination can be a powerful tool for treating

chromoblastomycosis

, as it demonstrated its effectiveness in both the lab and in a real-world case.

Synergistic Power: A New Weapon in the Fight Against Chromoblastomycosis

The results of this study are truly exciting! The combination of terbinafine and amphotericin B showed a synergistic effect, meaning that they work together to achieve a better outcome than either drug alone. This is like having two desert guides, each with their own expertise, working together to navigate a treacherous path. The combined knowledge of these two guides results in a much safer and smoother journey through the desert, just as the combined power of terbinafine and amphotericin B can lead to a more successful treatment for

chromoblastomycosis

.

Understanding the Potential of Synergistic Therapies

This research provides a valuable lesson on the potential of synergistic therapies. It’s like combining the strength of a camel’s endurance with the agility of a gazelle; each brings their own unique strengths to the table. This study suggests that by combining different therapies, we can unlock new and more effective ways to combat diseases. This approach could revolutionize the treatment of various infections and diseases, offering new hope for patients.

Dr.Camel's Conclusion

This research is a testament to the power of collaboration in the world of medicine. Just like a group of desert nomads working together to overcome a challenge, this study shows that combining different approaches can lead to more effective treatments. The synergistic effect of terbinafine and amphotericin B is a shining example of this principle, and it opens up exciting new possibilities for combating fungal infections.

Date :
  1. Date Completed 2019-07-15
  2. Date Revised 2020-02-25
Further Info :

Pubmed ID

31241660

DOI: Digital Object Identifier

PMC6592013

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.